Related Experiment Video
Updated: Jun 20, 2026
09:38
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
[Therapy of multiple sclerosis]
1Semmelweis Egyetem, Neurológiai Klinika, Budapest.
Summary
Multiple sclerosis (MS) is a common neuroimmunological disorder affecting the central nervous system. Early diagnosis and treatment are crucial for managing this multifactorial autoimmune disease.
Area of Science:
- Neuroimmunology
- Central Nervous System Disorders
Context:
- Multiple sclerosis (MS) is a frequent neuroimmunological disorder impacting the central nervous system.
- It's a multifactorial condition influenced by genetic and environmental factors.
- MS involves autoimmune inflammation leading to myelin and axonal damage.
Purpose:
- To provide an overview of multiple sclerosis (MS).
- To discuss its pathological subtypes, clinical courses, and diagnostic criteria.
- To outline therapeutic approaches and differential diagnoses.
Summary:
- MS is characterized by autoimmune inflammation, myelin damage, and axonal loss in the CNS.
- Diagnosis relies on clinical presentation and MRI findings per revised McDonald criteria.
- Treatment includes acute relapse management, symptomatic relief, and immunomodulatory therapies.
Impact:
- Highlights the importance of distinguishing MS from neuromyelitis optica for timely intervention.
- Emphasizes the need for early diagnosis to prevent severe residual symptoms.
- Underscores the complexity of MS management involving various treatment strategies.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications